Ceryx Condusts First-In-Human Study of Cysoni Pacemaker for Heart Failure Patients
Ceryx Medical Ltd has initiated the first-in-human study of its Cysoni™ RSA Pacemaker’s potential to provide superior treatment for heart failure patients by boosting cardiac output through Respiratory Sinus Arrhythmia (RSA) inputs.
Read more: https://nextdigitalhealth.com/healthcare/cardiac-care/ceryx-condusts-first-in-human-study-of-cysoni-pacemaker-for-heart-failure-patients/
#HealthcareNews #HealthcareInnovation #HealthcareTechnology #Ai #Medicaldevice
Ceryx Medical Ltd has initiated the first-in-human study of its Cysoni™ RSA Pacemaker’s potential to provide superior treatment for heart failure patients by boosting cardiac output through Respiratory Sinus Arrhythmia (RSA) inputs.
Read more: https://nextdigitalhealth.com/healthcare/cardiac-care/ceryx-condusts-first-in-human-study-of-cysoni-pacemaker-for-heart-failure-patients/
#HealthcareNews #HealthcareInnovation #HealthcareTechnology #Ai #Medicaldevice
Ceryx Condusts First-In-Human Study of Cysoni Pacemaker for Heart Failure Patients
Ceryx Medical Ltd has initiated the first-in-human study of its Cysoni™ RSA Pacemaker’s potential to provide superior treatment for heart failure patients by boosting cardiac output through Respiratory Sinus Arrhythmia (RSA) inputs.
Read more: https://nextdigitalhealth.com/healthcare/cardiac-care/ceryx-condusts-first-in-human-study-of-cysoni-pacemaker-for-heart-failure-patients/
#HealthcareNews #HealthcareInnovation #HealthcareTechnology #Ai #Medicaldevice